JP2020528910A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020528910A5 JP2020528910A5 JP2020504133A JP2020504133A JP2020528910A5 JP 2020528910 A5 JP2020528910 A5 JP 2020528910A5 JP 2020504133 A JP2020504133 A JP 2020504133A JP 2020504133 A JP2020504133 A JP 2020504133A JP 2020528910 A5 JP2020528910 A5 JP 2020528910A5
- Authority
- JP
- Japan
- Prior art keywords
- oligonucleotide
- aspects
- composition according
- tablets
- series
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762538504P | 2017-07-28 | 2017-07-28 | |
| US62/538,504 | 2017-07-28 | ||
| PCT/US2018/043867 WO2019023439A1 (en) | 2017-07-28 | 2018-07-26 | PROCESS FOR THE PREPARATION OF OLIGONUCLEOTIDE COMPOUNDS |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020528910A JP2020528910A (ja) | 2020-10-01 |
| JP2020528910A5 true JP2020528910A5 (https=) | 2021-09-09 |
Family
ID=65041406
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020504133A Pending JP2020528910A (ja) | 2017-07-28 | 2018-07-26 | オリゴヌクレオチド化合物の調製方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20200392491A1 (https=) |
| EP (1) | EP3658155A4 (https=) |
| JP (1) | JP2020528910A (https=) |
| KR (1) | KR20200042902A (https=) |
| CN (1) | CN111148519A (https=) |
| WO (1) | WO2019023439A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2019505598A (ja) | 2016-02-23 | 2019-02-28 | セルジーン アルパイン インベストメント カンパニー Ｉｉ， エルエルシー | Ｓｍａｄ７の阻害を用いて、腸線維症を治療する方法 |
| CN113474633A (zh) * | 2019-02-26 | 2021-10-01 | 罗氏创新中心哥本哈根有限公司 | 寡核苷酸配制方法 |
| AU2020309307B2 (en) * | 2019-07-09 | 2023-03-30 | F. Hoffmann-La Roche Ag | Process for the deprotection of oligonucleotides |
| CN110468171B (zh) * | 2019-09-20 | 2021-10-29 | 凯莱英医药集团（天津）股份有限公司 | 核酸的合成方法 |
| WO2021168306A1 (en) * | 2020-02-21 | 2021-08-26 | Biogen Ma Inc. | Methods of preparing oligonucleotide compositions using ultrafiltration / diafiltration |
| WO2024138152A1 (en) * | 2022-12-23 | 2024-06-27 | Asahi Kasei Bioprocess America, Inc. | System for performing cleavage, deprotection, ultrafiltration, and diafiltration operations |
| CN117143165B (zh) * | 2023-08-30 | 2026-02-03 | 上海奥锐特生物科技有限公司 | 一种寡核苷酸的纯化方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007050789A2 (en) * | 2005-10-25 | 2007-05-03 | Nëdken Corporation | Glycosyl-oligonucleotide conjugates and methods |
| WO2014120861A2 (en) * | 2013-01-31 | 2014-08-07 | Isis Pharmaceuticals, Inc. | Method of preparing oligomeric compounds using modified coupling protocols |
| AU2015257589A1 (en) * | 2014-05-09 | 2016-11-24 | Nogra Pharma Limited | Methods for treating inflammatory bowel disease |
| WO2015011694A2 (en) * | 2014-10-17 | 2015-01-29 | Celgene Corporation | Isotopologues of smad7 antisense oligonucleotides |
| EP3355896A2 (en) * | 2015-09-30 | 2018-08-08 | Nogra Pharma Limited | Methods of using smad7 antisense oligonucleotides based on biomarker expression |
-
2018
- 2018-07-26 EP EP18837870.7A patent/EP3658155A4/en not_active Withdrawn
- 2018-07-26 KR KR1020207004894A patent/KR20200042902A/ko not_active Withdrawn
- 2018-07-26 CN CN201880062621.9A patent/CN111148519A/zh active Pending
- 2018-07-26 JP JP2020504133A patent/JP2020528910A/ja active Pending
- 2018-07-26 US US16/634,078 patent/US20200392491A1/en not_active Abandoned
- 2018-07-26 WO PCT/US2018/043867 patent/WO2019023439A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020528910A5 (https=) | ||
| JP7789856B2 (ja) | 活性剤の脂質ナノ粒子送達のための脂質 | |
| CN110944675B (zh) | 一种核酸、含有该核酸的组合物与缀合物及制备方法和用途 | |
| CN113150041B (zh) | 一种硫代寡核苷酸的制备方法 | |
| CN118291456A (zh) | 一种核酸、含有该核酸的组合物与缀合物及制备方法和用途 | |
| CN111655297A (zh) | 一种siRNA缀合物及其制备方法和用途 | |
| IL300119A (en) | Oligonucleotides to induce paternal UBE3A expression | |
| TW201825506A (zh) | 製備磷醯二胺嗎啉代寡聚物之方法 | |
| KR20190015311A (ko) | 올리고머의 제조 방법 | |
| JP2023515218A (ja) | Ｐｄ－ｌ１を標的とするための方法及び組成物 | |
| CN112876534A (zh) | 肝靶向化合物及缀合物 | |
| JP2020528910A (ja) | オリゴヌクレオチド化合物の調製方法 | |
| EP3286203B1 (en) | Methods of polynucleotide preparation using multivalent cation salt compositions | |
| TW201805002A (zh) | 磷醯二胺嗎啉代寡聚物醫藥組合物 | |
| TW202140789A (zh) | 靶向ｐｄ—ｌ１之方法及組合物 | |
| CN112007040A (zh) | 用于治疗乙型病毒性肝炎的联合用药物 | |
| Grajkowski et al. | An expedient process for reducing the formation of process-related impurities during solid-phase synthesis of potential nucleic acid-based drugs | |
| Zhu et al. | Preparation and physical properties of conjugates of oligodeoxynucleotides with poly (δ) ornithine peptides | |
| JP2003204793A (ja) | ウイルス性疾患の予防または治療剤 | |
| JP2000342265A (ja) | オリゴヌクレオチド類の精製方法 | |
| Sato et al. | New Molecular Technologies for Oligonucleotide Therapeutics-1: Properties and Synthesis of Boranophosphate DNAs | |
| JP2004107230A (ja) | ガラビオース結合カルボシランデンドリマー化合物 | |
| EP3805242A1 (en) | Method for the production of a catalytically active dna molecule having improved activity and its use in a method of treating asthma | |
| JPH02237930A (ja) | 新規オリゴデオキシヌクレオチドおよび該オリゴデオキシヌクレオチドを有効成分とする制癌剤 | |
| EA052594B1 (ru) | Конъюгат нуклеиновой кислоты и лиганда, способ его получения и его применения |